Braidwell’s Mineralys Therapeutics MLYS Stock Holding History

Braidwell’s Portfolio MLYS Stock Details MLYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,147,154	Closed	-$14.8M	–	82
2024 Q1	$14.8M	Sell	1,147,154 -876,746	-43%	-$10.8M	0.48%	56
2023 Q4	$17.4M	Hold	2,023,900	–	–	0.64%	45
2023 Q3	$19.2M	Buy	2,023,900 +1,473,600	+268%	+$19.2M	0.61%	54
2023 Q2	$9.38M	Hold	550,300	–	–	0.31%	72
2023 Q1	$8.62M	Buy	+550,300	New	+$9.26M	0.28%	69

Other funds holding MLYS

Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return